Anup Ghimire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anup Ghimire has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Achyut Sharma
Department of Anaesthesia, Pain Management, and Critical Care, Nepal Mediciti Hospital, Nakhkhu Patan, Karyabinayak, 44600, Nepal
1 shared publication - Anil Acharya
Nepal Mediciti
1 shared publication - Apurb Sharma
Department of Anesthesiology, Shahid Gangalal National Heart Center, Kathmandu, Nepal
1 shared publication - Ashim Regmi
Department of Anaesthesia, Pain Management, and Critical Care, Nepal Mediciti Hospital, Nakhkhu Patan, Karyabinayak, 44600, Nepal
1 shared publication - Bijoy G. Rajbanshi
Department of Cardiothoracic and Vascular Surgery, Nepal Mediciti Hospital, Nakhkhu Patan, Karyabinayak, 44600, Nepal
1 shared publication - Diptesh Aryal
Nepal Intensive Care Research Foundation, Kathmandu, Nepal
1 shared publication
Latest Publications
- Open Access
- 28 October 2018
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 12 (1) , 1-5
Extracorporeal membrane oxygenation in aluminum phosphide poisoning in Nepal: a case report
Aluminum phosphide is a very common suicide agent in developing countries like Nepal. Due to the unavailability of a specific antidote, mortality is very high because the phosphine molecule that is formed leads to inhibition of the cytochrome oxidase enzyme system in mitochondria. Extracorporeal membrane oxygenation provides life-saving support to the cardiovascular and respiratory systems until the deadly poison is eliminated from the body. We encountered one case of 67-year-old Asian woman, a known case of major depressive disorder, who presented to our center with suicidal ingestion of aluminum phosphide with cardiovascular and respiratory dysfunction. On presentation in our emergency room, she had an ejection fraction of 20% and had to be immediately intubated for respiratory failure. Based on the evidence of almost 100% mortality with aluminum phosphide poisoning, extracorporeal membrane oxygenation was initiated in our intensive care unit. Her general condition and hemodynamics gradually improved over the course of 2 days and she was weaned from extracorporeal membrane oxygenation and ventilator by post-extracorporeal membrane oxygenation days 3 and 4, respectively. After psychiatric evaluation and establishment of normal vital parameters, she was moved out of intensive care unit on post-extracorporeal membrane oxygenation day 6 and discharged to home on post-extracorporeal membrane oxygenation day 10. Although this seems to be a small step in terms of global perspective, it is a giant stride for a developing country. The management of reversible but severe cardiac and respiratory failure certainly opens up newer scopes where we can ensure a quality health care service being made accessible even to the most underprivileged people.
- 28 October 2018
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 12 (1) , 1-5
Open AccessExtracorporeal membrane oxygenation in aluminum phosphide poisoning in Nepal: a case report
Aluminum phosphide is a very common suicide agent in developing countries like Nepal. Due to the unavailability of a specific antidote, mortality is very high because the phosphine molecule that is formed leads to inhibition of the cytochrome oxidase enzyme system in mitochondria. Extracorporeal membrane oxygenation provides life-saving support to the cardiovascular and respiratory systems until the deadly poison is eliminated from the body. We encountered one case of 67-year-old Asian woman, a known case of major depressive disorder, who presented to our center with suicidal ingestion of aluminum phosphide with cardiovascular and respiratory dysfunction. On presentation in our emergency room, she had an ejection fraction of 20% and had to be immediately intubated for respiratory failure. Based on the evidence of almost 100% mortality with aluminum phosphide poisoning, extracorporeal membrane oxygenation was initiated in our intensive care unit. Her general condition and hemodynamics gradually improved over the course of 2 days and she was weaned from extracorporeal membrane oxygenation and ventilator by post-extracorporeal membrane oxygenation days 3 and 4, respectively. After psychiatric evaluation and establishment of normal vital parameters, she was moved out of intensive care unit on post-extracorporeal membrane oxygenation day 6 and discharged to home on post-extracorporeal membrane oxygenation day 10. Although this seems to be a small step in terms of global perspective, it is a giant stride for a developing country. The management of reversible but severe cardiac and respiratory failure certainly opens up newer scopes where we can ensure a quality health care service being made accessible even to the most underprivileged people.